🇺🇸 FDA
Patent

US 10464918

Process of making somatostatin modulators

granted A61PA61P35/00

Quick answer

US patent 10464918 (Process of making somatostatin modulators) held by CRINETICS PHARMACEUTICALS, INC. expires Mon Oct 31 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
CRINETICS PHARMACEUTICALS, INC.
Grant date
Tue Nov 05 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 31 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
24
CPC classes
A61P, A61P35/00